First, baseline serum levels of VCAM-1, E-selectin, ACE2 and Lp-PLA2 were retrospectively measured to evaluate the degree of vascular disorders with endothelial cell activation and to compare them among study sub-cohorts (Figure 1A–D). The gene discussed is ACE2; the disease is vascular disorder.